secwatch.observer — SEC 8-K summary
======================================

Issuer:     QHSLab, Inc. (USAQ)
CIK:        0000856984
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001493152-24-047553
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QHSLab reports Oct sales up 110% to $225k; APA abstracts accepted for 2025
--------------------------------------------------------------------------

- October 2024 unaudited sales ~$225,000, a 110% increase YoY; annualized run rate $2.7M.
- Two research abstracts accepted for presentation at 2025 APA Annual Meeting in Los Angeles.
- DMAR study (allergic rhinitis) reached second milestone; participant recruitment exceeded projections.
- Company highlights reductions in symptom severity and improved quality of life in mental health studies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/856984/000149315224047553/0001493152-24-047553-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/856984/000149315224047553/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047553

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer